Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2023

Conditions
Solid Carcinoma
Interventions
PROCEDURE

fecal microbiota transplantation

Fecal microbiota transplantation (FMT) is the administration of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient's microbial composition and confer a health benefit

Trial Locations (1)

05505

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT04264975 - Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology | Biotech Hunter | Biotech Hunter